23andMe is a personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service enables individuals to gain deeper insights into their ancestry and genetic make-up. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research.
Company Growth (employees)
Type
Private
HQ
Mountain View, US
Founded
2006
Size (employees)
419 (est)+2%
23andMe was founded in 2006 and is headquartered in Mountain View, US

Key People at 23andMe

Anne Wojcicki

Anne Wojcicki

CEO and Co-founder
Dean Schorno

Dean Schorno

CFO & Head of Operations
Angela Calman

Angela Calman

Vice President of Communications
Emily Drabant Conley

Emily Drabant Conley

Vice President of Business Development
Joyce Tung

Joyce Tung

Vice President of Research
Jonathan Ward

Jonathan Ward

Vice President, International
Kathy Hibbs

Kathy Hibbs

Chief Legal and Regulatory Officer
Steve Lemon

Steve Lemon

VP, Product & Engineering

23andMe Office Locations

23andMe has an office in Mountain View
Mountain View, US (HQ)
899 W Evelyn Ave

23andMe Data and Metrics

Summary Metrics

23andMe's latest funding round in October 2016 was reported to be $1.7 m. In total, 23andMe has raised $236.1 m. 23andMe's latest valuation is reported to be $1.1 b.

23andMe Financial Metrics

USD

Market valuation

1.1 b

23andMe Operating Metrics

23andMe's Customers was reported to be 2 m in 2017
Y, 2015Y, 2017

Customers

800 k2 m

Countries

50

Phenotypic Data Points Collected

600 m

23andMe Median Salaries

Source: 13 public H-1B filings from 23andMe

Traffic Overview of 23andMe

23andMe Online and Social Media Presence

23andMe News and Updates

The FDA’s 23andMe decision will also change the rules for all at-home medical genetic testing

Doctors are losing their role as the gatekeeper of our health information, for better or worse. Last week, the US Food and Drug Administration made…

How 23andMe Won Back the Right to Foretell Your Diseases

Using science and lots of focus groups, the company convinced the FDA that people can understand genetic testing results. The post How 23andMe Won Back the Right to Foretell Your Diseases appeared first on WIRED.

Patient groups have a message for anyone thinking of taking 23andMe's new test

23andMe can once again tell you whether you have an increased risk of developing certain diseases. By the end of the month, 23andMe users will start to see some results among their other health and ancestry reports, including the results that tell you if you have an increas…

You can finally get an FDA-approved genetic test for diseases from 23andMe

23andMe is already telling curious customers everywhere they're descended from, but the genetics service has finally received permission to provide a little more information based on DNA samples.  23andMe now has approval from the Food and Drug Administration to tell its users if they're at a hi…

23andMe is finally allowed to tell you if you have the genes for Parkinson’s

 The Food and Drug Administration finally gave 23andMe a long sought-after green light today to sell to consumers genetic tests and their accompanying health risk reports for up to 10 diseases, including late-onset Alzheimer’s and Parkinson’s. Read More

23andMe just got the OK to tell you if you have an increased risk of Alzheimer's, Parkinson's and other diseases

23andMe can once again tell you if you have an increased risk of developing certain diseases.  In November 2013, the FDA barred 23andMe from sending any of that data related to health to customers because of concerns that the company was misrepresenting genetic tests as medi…
Show more

23andMe Company Life and Culture

You may also be interested in